- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
La Jolla Pharmaceutical Co
+ Add to WatchlistLJPC:US
0.0850 USD 0.0080 10.39%As of 20:10:00 ET on 05/24/2013.
Snapshot for La Jolla Pharmaceutical Co (LJPC)
| Open: | 0.0800 | Day's Range: | 0.0730 - 0.0888 | Volume: | 51,270 |
|---|---|---|---|---|---|
| Previous Close: | 0.0850 | 52wk Range: | 0.0400 - 0.1400 | 1-Yr Rtn: | +54.26% |
Key Statistics for LJPC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -30.8500 |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 2.59 |
| Shares Outstanding (M) | 30.49 |
| 30 Day Average Volume | 337,272 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LJPC
Company Profile & Key Executives for LJPC
La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.
| George F TidmarshPresident/CEO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LJPC News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page